IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0009531
(2011-01-19)
|
등록번호 |
US-8795224
(2014-08-05)
|
발명자
/ 주소 |
- Starkweather, Timothy J.
- Lebel, Ronald J.
- Shah, Rajiv
- Miller, Michael E.
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
30 인용 특허 :
29 |
초록
▼
A system and method for providing closed loop infusion formulation delivery which accurately calculates a delivery amount based on a sensed biological state by adjusting an algorithm's programmable control parameters. The algorithm calculates a delivery amount having proportional, derivative, and ba
A system and method for providing closed loop infusion formulation delivery which accurately calculates a delivery amount based on a sensed biological state by adjusting an algorithm's programmable control parameters. The algorithm calculates a delivery amount having proportional, derivative, and basal rate components. The control parameters may be adjusted in real time to compensate for changes in a sensed biological state that may result from daily events. Safety limits on the delivery amount may be included in the algorithm. The algorithm may be executed by a computing element within a process controller for controlling closed loop infusion formulation delivery. The biological state is sensed by a sensing device which provides a signal to the controller. The controller calculates an infusion formulation delivery amount based on the signal and sends commands to an infusion formulation delivery device which delivers an amount of infusion formulation determined by the commands.
대표청구항
▼
1. A method for delivering an insulin formulation, the method comprising: taking a plurality of samples of a blood glucose level over a period of time;calculating a difference between the blood glucose level of each of the plurality of samples and a predefined blood glucose level threshold;calculati
1. A method for delivering an insulin formulation, the method comprising: taking a plurality of samples of a blood glucose level over a period of time;calculating a difference between the blood glucose level of each of the plurality of samples and a predefined blood glucose level threshold;calculating a rate of change over time in the blood glucose level of each of the plurality of samples;calculating a sum comprising a first proportion of said calculated difference and a second proportion of said calculated rate of change, the second proportion including a trend term based on a timeframe; anddelivering an amount of insulin formulation based on an amount of said sum,wherein the trend term is disabled if the blood glucose level of each of the plurality of samples is less than the predefined blood glucose level threshold. 2. The method recited in claim 1, wherein said calculated rate of change is based on a derivative of the blood glucose level of each of the plurality of samples as a function of time. 3. The method recited in claim 1, wherein an amount of said first proportion or said second proportion is selectively changeable. 4. The method recited in claim 3, wherein said second proportion is set as a first value when the blood glucose level of each of the plurality of samples is increasing over time and is set as a second value when the blood glucose level of each of the plurality of samples is decreasing over time. 5. The method recited in claim 1, wherein said sum further comprises a basal amount of insulin formulation. 6. The method recited in claim 5, wherein said basal amount of insulin formulation can be set to change as a part or time of a day changes. 7. The method recited in claim 6, further comprising: disabling the delivery of an amount of insulin formulation over that of said basal amount within a predefined amount of time of an event. 8. The method recited in claim 7, wherein said event is related to a meal, sleep, awakening, exercise, stress-inducing event, or medication. 9. The method recited in claim 6: wherein each sample of the plurality of samples is taken at a time that is separated by a time period from a time at which a next sample or a previous sample was taken;wherein, when the blood glucose level of each of the plurality of samples is falling over time, said time period is of increased length as compared to a previous time period. 10. The method recited in claim 5, wherein the basal amount or the second proportion is zero for the purpose of said sum when the blood glucose level of each of the plurality of samples is below a predefined threshold and the blood glucose level of each of the plurality of samples is falling over time. 11. A system for delivering an insulin formulation, the system comprising: a data acquisition unit for taking a plurality of samples of a blood glucose level over a period of time;a calculator for calculating a difference between the blood glucose level of each of the plurality of samples and a predefined blood glucose level threshold;wherein said calculator is further configured to calculate a rate of change over time in the blood glucose level of each of the plurality of samples acquired by the data acquisition unit;wherein said calculator is further configured to calculate a sum comprising a first proportion of said calculated difference and a second proportion of said calculated rate of change, the second proportion including a trend term based on a timeframe; anda controller for basing an amount of insulin formulation to be delivered on an amount of said sum,wherein the trend term is disabled if the blood glucose level of each of the plurality of samples is less than the predefined blood glucose threshold. 12. The system recited in claim 11, wherein said calculated rate of change is based on a derivative of the blood glucose level of each of the plurality of samples as a function of time. 13. The system recited in claim 11, wherein an amount of said first proportion or said second proportion is selectively changeable. 14. The system recited in claim 13, wherein said second proportion is set as a first value when the blood glucose level of each of the plurality of samples is increasing over time and is set as a second value when the blood glucose level of each of the plurality of samples is decreasing over time. 15. The system recited in claim 11, wherein said sum further comprises a basal amount of insulin formulation. 16. The system recited in claim 15, wherein said basal amount of insulin formulation can be set to change as a part or time of a day changes. 17. The system recited in claim 16, wherein said controller is further configured to disable the delivery of an amount of insulin formulation over that of said basal amount within a predefined amount of time of an event. 18. The system recited in claim 17, wherein said event is related to a meal, sleep, awakening, exercise, stress-inducing event, or medication. 19. The system recited in claim 15: wherein each sample of the plurality of samples is taken at a time that is separated by a time period from a time at which a next sample or a previous sample was taken;wherein, when the blood glucose level of each of the plurality of samples is falling over time, said time period is of increased length as compared to a previous time period. 20. The system recited in claim 15, wherein the basal amount or the second proportion is zero for the purposes of said sum when the blood glucose level of each of the plurality of samples is below a predefined threshold and the blood glucose level of each of the plurality of samples is falling over time.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.